📋 Tender Overview
Contract awarded for The acquisition of medicines various national programs lot-0004, title: -alteplasum 50mg, description: conform anexa 1 lot-0012, title: -atropinum 1 mg/ml 1 ml, description: cf anexa 1 lot-0013, title: -azithromycinum 500 mg, description: cf anexa 1 lot-0014, title: -aztreonamum 2 g, description: conform anexa 1 lot-0042, title: -ketoprofenum 100 mg/2 ml, description: cf anexa 1 lot-0071, title: -sugammadexum 100mg/ml, description: cf anexa 1 lot-0079, title: -acidum zoledronicum 4mg/5ml, description: cf anexa 1 lot-0082, title: -atezolizumab 1200 mg, description: cf anexa 1 lot-0091, title: -brentuximab vedotin 50 mg, description: cf anexa 1 lot-0130, title: -nivolumab 10 mg/ml 4 ml, description: cf anexa 1 lot-0131, title: -nivolumab 10 mg/ml 10 ml, description: cf anexa 1 lot-0132, title: -obinutuzumabum 1000 mg, description: cf anexa 1 lot-0144, title: -pertuzumabum 420 mg, description: cf anexa 1 lot-0145, title: -polatuzumab vedotin 30 mg, description: cf anexa 1 lot-0146, title: -polatuzumab vedotin 140 mg, description: cf anexa 1 lot-0158, title: -trastuzumabum emtansin 100 mg, description: cf anexa 1 lot-0159, title: -trastuzumabum emtansin 160 mg, description: cf anexa 1 lot-0161, title: -vaccin bcg (onco bcg 100) 100 mg, description: cf anexa 1 lot-0167, title: -atezolizumab 1200 mg cost volum, description: cf anexa 1 lot-0172, title: -ipilimumab 5 mg/ ml 10 ml 50 mg cost volum, description: cf anexa 1 lot-0174, title: -nivolumab 10 mg/ml 4 ml (40 mg) cost volum, description: cf anexa 1 lot-0175, title: -nivolumab 10 mg/ml 10 ml (100 mg) cost volum, description: cf anexa 1 lot-0181, title: -interferonum beta 1 b 250ug, description: cf anexa 1 lot-0184, title: -ocrelizumabum 300mg, description: cf anexa 1 lot-0185, title: -ocrelizumabum 920mg 40 mg/ml, description: cf anexa 1 lot-0188, title: -ofatumumabum 20mg, description: cf anexa 1 estimated value excluding vat: 3019200.00 ron.The acquisition of medicines various national programs